PSCR (Proto Script Pharmaceutical) Retained Earnings: $-8.74 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Retained Earnings?

Proto Script Pharmaceutical PSCR Retained Earnings is $-8.74 Mil as of Sep. 2017.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Proto Script Pharmaceutical's retained earnings for the quarter that ended in Sep. 2017 was $-8.74 Mil.

Proto Script Pharmaceutical's quarterly retained earnings declined from Mar. 2017 ($-8.12 Mil) to Jun. 2017 ($-8.46 Mil) and declined from Jun. 2017 ($-8.46 Mil) to Sep. 2017 ($-8.74 Mil).

Proto Script Pharmaceutical's annual retained earnings declined from May. 2014 ($-0.11 Mil) to May. 2015 ($-0.15 Mil) and declined from May. 2015 ($-0.15 Mil) to May. 2016 ($-0.19 Mil).

Proto Script Pharmaceutical  (OTCPK:PSCR) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Proto Script Pharmaceutical Retained Earnings Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Retained Earnings Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Retained Earnings
-0.04 -0.07 -0.11 -0.15 -0.19

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -7.62 -8.12 -8.46 -8.74

Proto Script Pharmaceutical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-8.74 Mil mean?
Proto Script Pharmaceutical (PSCR) has a Retained Earnings of $-8.74 Mil as of Sep. 2017. Retained earnings is the amount of net income not issued to shareholders. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Retained Earnings too high?
Proto Script Pharmaceutical's current Retained Earnings is $-8.74 Mil.
How does Proto Script Pharmaceutical's Retained Earnings compare to EXCC and NXES?
Proto Script Pharmaceutical's Retained Earnings of $-8.74 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Business Services company?
A good Retained Earnings depends on the Business Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Retained Earnings is $-8.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Retained Earnings of $-8.74 Mil. The current Retained Earnings is $-8.74 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Retained Earnings is $-8.74 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.